| View |
|
DR-XY45437
|
Metronidazole
|
Flagyzole
|
5 mg/mL (500 mg/100 mL)
|
Solution For Intravenous Infusion
|
Antiprotozoal (Imidazole derivative)
|
Friends Pharma (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
19 March 2021
|
10 June 2026
|
| View |
|
DR-XY45438
|
Ibuprofen
|
None
|
200 mg
|
Softgel Capsule
|
-
|
Phil Inter Pharma Co., Ltd.
|
Vietnam
|
Initial (Variation)
|
10 October 2022
|
10 October 2027
|
| View |
|
DR-XY45439
|
Ketamine (As Hydrochloride)
|
None
|
50 mg/mL
|
Solution For Injection
|
General Anesthetic
|
Myungmoon Pharmaceutical Co., Ltd.
|
Korea
|
Automatic Renewal
|
07 June 2023
|
08 June 2028
|
| View |
|
DR-XY45441
|
Tramadol Hydrochloride
|
Ramol
|
50 mg
|
Capsule
|
Opioid Analgesic
|
Macter International Ltd.
|
Pakistan
|
Automatic Renewal
|
24 June 2021
|
13 June 2026
|
| View |
|
DR-XY45442
|
Empagliflozin + Metformin Hydrochloride
|
Jardiance Duo
|
5mg/ 500mg
|
Film-Coated Tablet
|
Antidiabetic
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Initial (from Monitored Release status)
|
03 December 2021
|
16 June 2026
|
| View |
|
DR-XY45443
|
Empagliflozin + Metformin Hydrochloride
|
Jardiance Duo
|
5mg/ 850 mg
|
Film-Coated Tablet
|
Antidiabetic
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Initial (from Monitored Release status)
|
03 December 2021
|
16 June 2026
|
| View |
|
DR-XY45444
|
Empagliflozin + Metformin Hydrochloride
|
Jardiance Duo
|
5mg/1g
|
Film-Coated Tablet
|
-
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Initial (from Monitored Release)
|
07 December 2022
|
16 June 2027
|
| View |
|
DR-XY45445
|
Empagliflozin + Metformin Hydrochloride
|
Jardiance Duo
|
12.5mg/ 500mg
|
Film-Coated Tablet
|
-
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
-
|
03 December 2021
|
16 June 2026
|
| View |
|
DR-XY45446
|
Empagliflozin + Metformin Hydrochloride
|
Jardiance Duo
|
12.5mg/ 850mg
|
Film-Coated Tablet
|
Antidiabetic
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Initial (from Monitored Release status)
|
03 December 2021
|
16 June 2026
|
| View |
|
DR-XY45447
|
Empagliflozin + Metformin Hydrochloride
|
Jardiance Duo
|
12.5mg/1g
|
Film-Coated Tablet
|
Antidiabetic
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Initial (from Monitored Release status)
|
03 December 2021
|
16 June 2026
|
| View |
|
DR-XY45448
|
Ampicillin (As Sodium) + Sulbactam (As Sodium)
|
Sambactam [for Export only]
|
1g/ 500mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Renewal
|
10 June 2021
|
13 June 2026
|
| View |
|
DR-XY45449
|
Co-Amoxiclav
|
Klavic
|
500mg/ 125mg
|
Film-Coated Tablet
|
Antibacterial
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Renewal
|
01 June 2021
|
14 June 2026
|
| View |
DR-XY45452_PI_01.pdf
|
DR-XY45452
|
Perindopril (as arginine) + Amlodipine (as besilate)
|
Viacoram Initio
|
3.5mg/ 2.5mg
|
Tablet
|
-
|
Servier (Ireland) Industries Ltd.
|
Ireland
|
-
|
12 March 2021
|
20 June 2026
|
| View |
DR-XY45453_PI_01.pdf
|
DR-XY45453
|
Perindopril (as arginine) + Amlodipine (as besilate)
|
Coveram
|
7mg/ 5mg
|
Tablet
|
-
|
Servier (Ireland) Industries Ltd.
|
Ireland
|
-
|
12 March 2021
|
20 June 2026
|
| View |
|
DR-XY45454
|
Pancreatin
|
Creon 10000
|
Formulation: Each capsule is filled with enteric-coated minimicrospheres for oral administration containing 150 mg Pancreatin (pancreas powder) corresponding to:
Lipase-10000 Ph. Eur. Units Amylase- 8000 Ph. Eur. Units Protease-600 Ph. Eur. Units
|
Capsule
|
Digestive Enzyme Supplement
|
Abbott Laboratories GmbH
|
Germany
|
Automatic Renewal
|
26 March 2021
|
20 June 2026
|
| View |
|
DR-XY45455
|
Tobramycin
|
Nebra
|
3mg/ mL (0.3%)
|
Sterile Ophthalmic Solution
|
Antibacterial (Aminoglycoside)
|
Remington Pharmaceuticals Industries (Pvt) Ltd.
|
Pakistan
|
-
|
08 October 2021
|
16 June 2026
|
| View |
|
DR-XY45456
|
Cefuvic 250
|
Cefuroxime (As Axetil)
|
250 mg
|
Film-Coated Tablet
|
-
|
Sherrington Pharmaceuticals Pvt. Ltd.
|
India
|
-
|
20 May 2021
|
21 June 2026
|
| View |
|
DR-XY45460
|
Pantoprazole ( As Sodium )
|
Aepanpraz
|
40 mg
|
Powder for Solution for Injection (IV)
|
-
|
Yangtze River Pharmaceutical (Group) Co., Ltd.
|
China
|
Automatic Renewal
|
05 March 2021
|
04 July 2026
|
| View |
|
DR-XY45464
|
Multivitamins + Zinc
|
Bicovit-Z
|
Formulation: Each capsule contains: Ascorbic Acid (Vitamin C)-150mg Nicotinamide (Vitamin B3)-50mg Zinc (equivalent to 54.93 mg Zinc Sulfate Monohydrate)-20mg Calcium Pantothenate-12.5mg Thiamine nitrate (Vitamin B1)-10mg Riboflavin (Vitamin B2)-10mg Pyridoxine Hydrochloride (Vitamin B6)-3mg Folic Acid-1mg Cyanocobalamin (Vitamin B12)-15mcg
|
Capsule
|
-
|
Sai Mirra Innopharm Pvt. Ltd.
|
India
|
-
|
16 April 2021
|
30 June 2026
|
| View |
|
DR-XY45466
|
Ciprofloxacin
|
Cipronat
|
2mg/ mL
|
Solution for Infusion (I.V.)
|
Antibacterial (Quinolone)
|
Yuria-Pharm Ltd.
|
Ukraine
|
Automatic Renewal
|
03 July 2021
|
23 June 2026
|